Cargando…

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

Background: Pirfenidone is an anti-fibrotic agent used to treat patients with idiopathic pulmonary fibrosis (IPF). Managing adverse drug events and ensuring compliance with pirfenidone treatment for a prolonged period are important to reduce the rate of disease progression. To maximize the benefits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satsuma, Yukari, Ikesue, Hiroaki, Kusuda, Kaori, Maeda, Mami, Muroi, Nobuyuki, Mori, Ryobu, Kogo, Mariko, Hirabayashi, Ryosuke, Nagata, Kazuma, Nakagawa, Atsushi, Tachikawa, Ryo, Tomii, Keisuke, Hashida, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725709/ https://www.ncbi.nlm.nih.gov/pubmed/33324201 http://dx.doi.org/10.3389/fphar.2020.529654

Ejemplares similares

Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer
por: Ikesue, Hiroaki, et al.
Publicado: (2020)

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19
por: Tamura, Ryo, et al.
Publicado: (2023)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Association between 25-hydroxyvitamin D levels and COVID-19 severity
por: Takase, Tomoki, et al.
Publicado: (2022)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban
por: Takase, Tomoki, et al.
Publicado: (2019)

Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study
por: Yamashita, Kanae, et al.
Publicado: (2021)

The validity and reliability of four-meter gait speed test for stable interstitial lung disease patients: the prospective study
por: Hirabayashi, Ryosuke, et al.
Publicado: (2020)

Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study
por: Hirabayashi, Ryosuke, et al.
Publicado: (2023)

Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study
por: Kogo, Mariko, et al.
Publicado: (2020)

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer
por: Tohi, Makiko, et al.
Publicado: (2023)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
por: Tanaka, Fumiaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib
por: Ikesue, Hiroaki, et al.
Publicado: (2022)

What Is the Impact of Mildly Altered Consciousness on Acute Hypoxemic Respiratory Failure with Non-invasive Ventilation?
por: Kogo, Mariko, et al.
Publicado: (2018)

Altered Consciousness, Non-invasive Ventilation, and Hypoxemic Respiratory Failure: The Trident Question Unresolved - Reply
por: Kogo, Mariko, et al.
Publicado: (2019)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma
por: Yamaoka, Kenta, et al.
Publicado: (2023)

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication
por: Tanaka, Fumiaki, et al.
Publicado: (2023)

Longitudinal changes in mental health outcomes after COVID-19 hospitalization: A prospective study
por: Shirakawa, Chigusa, et al.
Publicado: (2023)

Evaluating the safety and efficiency of robotic dispensing systems
por: Takase, Tomoki, et al.
Publicado: (2022)

Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
por: Fujimoto, Daichi, et al.
Publicado: (2016)

A case of pleural effusion caused by Mycobacterium fortuitum and Mycobacterium mageritense coinfection
por: Hirabayashi, Ryosuke, et al.
Publicado: (2019)

Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital
por: Matsumoto, Takeshi, et al.
Publicado: (2015)

Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature
por: Mori, Ryobu, et al.
Publicado: (2017)

Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database
por: Hasegawa, Shiori, et al.
Publicado: (2022)

The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
por: Sato, Yuki, et al.
Publicado: (2016)

Pirfenidone: is it tolerable?
por: Lara, Abigail, et al.
Publicado: (2016)

Management of alveolar‐pleural fistula secondary to invasive pulmonary aspergillosis with bronchial occlusion using a combination of Endobronchial Watanabe Spigot and N‐butyl‐2‐cyanoacrylate: A case report
por: Tsukamoto, Shinya, et al.
Publicado: (2023)

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery
por: Takase, Tomoki, et al.
Publicado: (2018)

Pirfenidone-induced Eosinophilic Pleurisy
por: Hase, Isano, et al.
Publicado: (2017)

Biphasic Effect of Pirfenidone on Angiogenesis
por: Gan, Donghao, et al.
Publicado: (2022)

Inhibition of Ureteral Stricture by Pirfenidone-Loaded Nanoparticle-Coated Ureteral Stents with Slow-Release Pirfenidone
por: Jiang, Zhaosheng, et al.
Publicado: (2022)

The Efficacy and Safety of Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis
por: Ogawa, Kazumasa, et al.
Publicado: (2018)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Role of pirfenidone in the management of pulmonary fibrosis
por: Meyer, Keith C, et al.
Publicado: (2017)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis
por: Yamamoto, Haruna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_36cbt85b0v01eknqhq0qvkibo2